GUIDELINES FOR ACCURATE GENOTYPING OF SARS-COV-2 USING AMPLICON-BASED SEQUENCING OF CLINICAL SAMPLES

Our team at SOPHiA GENETICS has worked tirelessly over the past months to help advance the efforts of SARS-CoV-2 surveillance and research. During the first stages of the pandemic, we leveraged our experience in NGS to develop and fine-tune a robust solution to conduct full-genome analysis of SARS-CoV-2. Genotyping of the virus has been instrumental to …

GUIDELINES FOR ACCURATE GENOTYPING OF SARS-COV-2 USING AMPLICON-BASED SEQUENCING OF CLINICAL SAMPLES Read More »

New results to be Presented at The BRAIN Foundation Synchrony 2020 Conference

STALICLA will present new data from the biological characterization of a novel DEPI-identified endophenotype within Autism Spectrum Disorder (ASD): ASD Phenotype 1 (ASD-Phen1) at The BRAIN Foundation Synchrony 2020 conference Dec. 12th 2020. About the Presentation at Synchrony SymposiumMs Lynn Durham’s presentation entitled “Creating an Integrated Framework to Enable Precision Medicine Drug Development and Clinical Trials in ASD” will …

New results to be Presented at The BRAIN Foundation Synchrony 2020 Conference Read More »

transmutex - 4seeventures

Thinking slow about Nuclear power

“69% of French people and 86% of 18-34 year olds think that nuclear power contributes to climate change. Complete nonsense of course… but not that surprising. And not necessarily a problem of ignorance. READ MORE

SOPHIA GENETICS RAISES $110 MILLION IN OVERSUBSCRIBED NEW FUNDING ROUND

Supporting the Company’s Global Expansion to Meet Growing Clinical and Biopharma Demand for Data-Driven Medicine ·      SOPHiA GENETICS enters next stage of its global expansion with oversubscribed Series F round exceeding $110 million, led by major health-tech fund and followed by strategic industry leader ·      Company demonstrates solidity of its business model with banks joining …

SOPHIA GENETICS RAISES $110 MILLION IN OVERSUBSCRIBED NEW FUNDING ROUND Read More »

What is Dexter’s addressable market? Why? And what size is it?

Michael Friedrich got to discuss pressing and curious questions with the Handelszeitung. Fun and curious questions included: “If Distalmotion were music, what music would you be?” or “Who is your role model?”. Michael also shared insights into Distalmotion’s approach to robotic surgery, Dexter’s design, and distinct value-adding benefits, as well as an outlook into the …

What is Dexter’s addressable market? Why? And what size is it? Read More »

Latin America’s largest medical diagnostic company taps into SOPHiA’s new multimodal solution to fight cancer, fostering a new Data-Driven Medicine era

São Paulo, Brazil, July 23, 2020: SOPHiA GENETICS, leader in Data-Driven Medicine, announced today the signature of a Trial Match agreement with Dasa, the largest medical diagnostic company in Latin America. The group chose the SOPHiA Platform to lead the region toward an extensive approach to Data-Driven Medicine powered by the world’s first integrated multimodal …

Latin America’s largest medical diagnostic company taps into SOPHiA’s new multimodal solution to fight cancer, fostering a new Data-Driven Medicine era Read More »

LumiThera Closes Series C Round of Financing – LumiThera US

SEATTLE, July 8, 2020 /PRNewswire/ — LumiThera Inc., a commercial stage private medical device company, creating a multi-wavelength photobiomodulation (PBM) treatment for ocular disorders and diseases, today announced it has completed its Series C financing. The company raised approximately $14M to support further commercialization of its Valeda Light Delivery System for the treatment for dry …

LumiThera Closes Series C Round of Financing – LumiThera US Read More »